DXCM
Companies
NASDAQ
Dexcom Inc.
Health Care
$79.84
+$2.07 (+2.66%)
Price Chart
Overview
About DXCM
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Market Cap
$46.0B
Volume
304.2M
Avg. Volume
361.7M
P/E Ratio
43.024628
Dividend Yield
0.00%
Employees
7.5K
Company Information
Latest News for DXCM
Risk & Correlation Analysis
Market Correlation
1.02
Moderate Correlation
Volatility
High (0.49)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, DXCM shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$46.0B
Volume304.2M
P/E Ratio43.02
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 2, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025